Prostaglandin E2 receptor EP4 regulates cell migration via Orai1.
The EP4 prostanoid receptors are one of the four receptor subtypes for Prostaglandin E2 (PGE2 ). Therefore, EP4 may play an important role in cancer progression. However, little information is available regarding the function per se, including migration and the cellular signaling pathway of EP4 in oral cancer. First, we found that the mRNA and protein expression of EP4 was abundantly expressed in the human-derived tongue squamous cell carcinoma cell lines HSC-3 and OSC-19. The EP4 agonist (ONO-AE1-437) significantly promoted cell migration in HSC-3 cells. In contrast, knockdown of EP4 reduced cell migration. Furthermore, we confirmed that knock down of EP4 suppressed the metastasis of oral cancer cells in the lungs of mice in vivo. Therefore, we focused on the mechanism of migration/metastasis in EP4 signaling. Interestingly, EP4 agonist significantly induced intracellular Ca2 + elevation in not only oral cancer cells but also other cells, including normal cells. Furthermore, we found that EP4 activated phosphatidylinositol-3 kinase (PI3K) and induced Ca2+ influx via Orai1 without activation of store depletion and stromal interaction molecule 1 (STIM1). Immunoprecipitation showed that EP4 formed complexes to Orai1 and TRPC1, not STIM. Moreover, the EP4 agonist ONO-AE1-437 phosphorylated extracellular-signal-regulation kinase (ERK) and activated matrix metalloproteinase (MMP)-2 and MMP-9. Knockdown of Orai1 negated EP4 agonist-induced ERK phosphorylation. Taken together, our data suggested that EP4 activated PI3K and then induced Ca2+ influx from the extracellular space via Orai1, resulting in ERK phosphorylation and promoting cell migration. Migration is regulated by EP4/PI3K/Orai1 signaling in oral cancer.